Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
American Cryostem Corp
(OP:
CRYO
)
N/A
UNCHANGED
Last Price
Updated: 3:04 PM EDT, Apr 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.0001
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
American CryoStem Announces Patient Treatment Status for its Phase I Clinical Trial for Post-Concussion Syndrome (PCS)
March 04, 2022
EATONTOWN, NJ / ACCESSWIRE / March 4, 2022 / American CryoStem Corporation (OTC PINK:CRYO) a clinical stage biotechnology company, global licensor, and a pioneer in autologous cellular processing and...
From
American CryoStem Corporation
Via
AccessWire
American CryoStem Announces Completion of Patient Recruitment for its Post-Concussion Syndrome (PCS) ATCELL(TM) Phase I Clinical Trial
December 22, 2021
EATONTOWN, NJ / ACCESSWIRE / December 22, 2021 / American CryoStem Corporation (OTC PINK:CRYO) a clinical-stage biotechnology company, global licensor, and a pioneer in autologous cellular processing...
From
American CryoStem Corporation
Via
AccessWire
Performance
More News
Read More
American CryoStem Completes Clinical Protocol Design for Long COVID Study
November 30, 2021
From
American CryoStem Corporation
Via
AccessWire
Topics
Intellectual Property
American CryoStem Announces the Addition of John Schwartz, PhD to Its Advisory Board
November 23, 2021
From
American CryoStem Corporation
Via
AccessWire
Topics
Intellectual Property
American CryoStem to Study New Standardized Treatment Protocols for Wound Healing
November 16, 2021
From
American CryoStem Corporation
Via
AccessWire
Topics
Intellectual Property
American CryoStem Enters into an Agreement to Exchange Shares held by ACS Global, Inc
November 12, 2021
From
American CryoStem Corporation
Via
AccessWire
Topics
Intellectual Property
American CryoStem Executes LOI with Advanced Regenerative Associates to Conduct Wound Healing Clinical Study
May 06, 2021
From
American CryoStem Corporation
Via
AccessWire
Frequently Asked Questions
Is American Cryostem Corp publicly traded?
Yes, American Cryostem Corp is publicly traded.
What exchange does American Cryostem Corp trade on?
American Cryostem Corp trades on the OTC Traded
What is the ticker symbol for American Cryostem Corp?
The ticker symbol for American Cryostem Corp is CRYO on the OTC Traded
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today